Helmholtz Gemeinschaft


EU-OPENSCREEN: a novel collaborative approach to facilitate chemical biology

PDF (Original article) - Requires a PDF viewer such as GSview, Xpdf or Adobe Acrobat Reader
PDF (Supplemental Material) - Requires a PDF viewer such as GSview, Xpdf or Adobe Acrobat Reader

Item Type:Article
Title:EU-OPENSCREEN: a novel collaborative approach to facilitate chemical biology
Creators Name:Brennecke, P. and Rasina, D. and Aubi, O. and Herzog, K. and Landskron, J. and Cautain, B. and Vicente, F. and Quintana, J. and Mestres, J. and Stechmann, B. and Ellinger, B. and Brea, J. and Kolanowski, J.L. and Pilarski, R. and Orzaez, M. and Pineda-Lucena, A. and Laraia, L. and Nami, F. and Zielenkiewicz, P. and Paruch, K. and Hansen, E. and von Kries, J.P. and Neuenschwander, M. and Specker, E. and Bartunek, P. and Simova, S. and Leśnikowski, Z. and Krauss, S. and Lehtiö, L. and Bilitewski, U. and Brönstrup, M. and Taskén, K. and Jirgensons, A. and Lickert, H. and Clausen, M.H. and Andersen, J.H. and Vicent, M.J. and Genilloud, O. and Martinez, A. and Nazaré, M. and Fecke, W. and Gribbon, P.
Abstract:Compound screening in biological assays and subsequent optimization of hits is indispensable for the development of new molecular research tools and drug candidates. To facilitate such discoveries, the European Research Infrastructure EU-OPENSCREEN was founded recently with the support of its member countries and the European Commission. Its distributed character harnesses complementary knowledge, expertise, and instrumentation in the discipline of chemical biology from 20 European partners, and its open working model ensures that academia and industry can readily access EU-OPENSCREEN's compound collection, equipment, and generated data. To demonstrate the power of this collaborative approach, this perspective article highlights recent projects from EU-OPENSCREEN partner institutions. These studies yielded (1) 2-aminoquinazolin-4(3 H)-ones as potential lead structures for new antimalarial drugs, (2) a novel lipodepsipeptide specifically inducing apoptosis in cells deficient for the pVHL tumor suppressor, (3) small-molecule-based ROCK inhibitors that induce definitive endoderm formation and can potentially be used for regenerative medicine, (4) potential pharmacological chaperones for inborn errors of metabolism and a familiar form of acute myeloid leukemia (AML), and (5) novel tankyrase inhibitors that entered a lead-to-candidate program. Collectively, these findings highlight the benefits of small-molecule screening, the plethora of assay designs, and the close connection between screening and medicinal chemistry within EU-OPENSCREEN.
Keywords:Chemical Biology, Screening, Medicinal Chemistry, Open Access, Compound Library
Source:SLAS Discovery
Publisher:Sage Publications
Page Range:398-413
Date:1 March 2019
Official Publication:https://doi.org/10.1177/2472555218816276
PubMed:View item in PubMed

Repository Staff Only: item control page


Downloads per month over past year

Open Access
MDC Library